Philippe Compagnon

Inserm, Centre Hospitalier Universitaire Henri-Mondor, Assistance Publique – Hôpitaux de Paris

Papers

Total Citations

118

H-Index

About

Dr. Philippe Compagnon is a leading hepatobiliary and transplant surgeon whose research focuses on advancing minimally invasive liver surgery and understanding biliary pathology. His most impactful work centers on comparing robotic-assisted and laparoscopic techniques for liver resections, particularly left lateral sectionectomy. In a landmark 2016 propensity score-matched cohort study (64 citations), Dr. Compagnon demonstrated that while robotic-assisted left lateral sectionectomy offers comparable short-term outcomes to the laparoscopic approach, it is associated with significantly higher procedural costs—a critical finding for surgical decision-making and healthcare economics. His comprehensive 2016 review on robot-assisted laparoscopic liver resection (28 citations) further established his expertise in synthesizing evidence on this emerging technology, highlighting its potential benefits and current limitations. Beyond surgical innovation, Dr. Compagnon has made notable contributions to biliary tumor biology, co-authoring a 2014 study (26 citations) that identified BRAF V600E mutations in bile duct adenomas, providing new insights into the pathogenesis of these rare benign lesions. His work bridges cutting-edge surgical technique with molecular pathology, making him a respected voice in the evolution of hepatobiliary surgery.